S. Madonick

发表

Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.

A. Belger, J. Krystal, T. Cooper, 2005, Archives of general psychiatry.

Best practices: racial and ethnic effects on antipsychotic prescribing practices in a community mental health center.

S. Woods, E. Diaz, M. Sullivan, 2003, Psychiatric services.

Potentiation of Low Dose Ketamine Effects by Naltrexone: Potential Implications for the Pharmacotherapy of Alcoholism

A. Belger, J. Krystal, R. Gueorguieva, 2006, Neuropsychopharmacology.

Pilot study of Intravenous Nicotine Effects on Cognitive Performance in Schizophrenia

D. Boggs, D. D’Souza, M. Ranganathan, 2013, Schizophrenia Research.

Substance Abuse as a Risk Factor for Schizophrenia and Related Disorders

N. Boutros, D. D’Souza, M. Bowers, 2001 .

NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders.

A. Belger, J. Krystal, D. Charney, 1999, Harvard review of psychiatry.

Clinical and Sensorimotor Gating Effects of Ketamine in Normals

Erica Duncan, John Rotrosen, J. Rotrosen, 2001, Neuropsychopharmacology.

Effects of smoking on acoustic startle and prepulse inhibition in humans

J. Rotrosen, Erica Duncan, B. Angrist, 2001, Psychopharmacology.

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

Ralitza Gueorguieva, J. Krystal, T. Cooper, 2005, Biological Psychiatry.

Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine

A. Belger, J. Krystal, J. Seibyl, 2005, Psychopharmacology.

Effect of treatment status on prepulse inhibition of acoustic startle in schizophrenia

J. Rotrosen, B. Angrist, S. Madonick, 2003, Psychopharmacology.

Impaired prepulse inhibition of acoustic startle in schizophrenia

J. Rotrosen, Erica Duncan, M. Sanfilipo, 2000, Biological Psychiatry.

Review of international early psychosis programmes and a model to overcome unique challenges to the treatment of early psychosis in the United States

S. Madonick, D. Vaughan, Patricia Graham, 2015, Early intervention in psychiatry.

elta-9-Tetrahydrocannabinol Effects in chizophrenia : Implications for Cognition , sychosis , and Addiction eepak

J. Krystal, T. Cooper, R. Gueorguieva, 2005 .

Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients

J. Krystal, D. D’Souza, S. Madonick, 1999, Schizophrenia Research.

Enhanced Sensitivity to the Euphoric Effects of Alcohol in Schizophrenia

John H Krystal, Ralitza Gueorguieva, J. Krystal, 2006, Neuropsychopharmacology.

Review of international early psychosis programmes and a model to overcome unique challenges to the treatment of early psychosis in the United States

S. Madonick, D. Vaughan, Patricia Graham, 2015, Early intervention in psychiatry.